Two industry leaders unite to create and deliver what is likely the most valuable, efficient and cost-effective all-natural concept on the CBD market today.
PITTSBURGH, April 19, 2022 /PRNewswire/ — Hemp Synergistics, a leader in the cannabis industry, announced today they have joined forces with Rinus Beintema, one of Europe’s most recognized medical cannabis proponents, to deliver long sought relief with ground breaking hemp-infused treatments for thousands of pain and symptom sufferers.
Soaring patient-satisfaction rates proved the success of this new powder. Clinical trials were conducted with 300 volunteers, with 82% reporting the same or better effects from the new solution over the oil-based product, an amazing result considering the hefty reduction in the amount consumed.
Suver Nuver has since expanded their clinical trials to over 30,000 patients. This will be followed by a full-country roll-out in Netherlands in Q3 and expansion into Germany in Q4.
“We have joined forces to create and deliver what is likely the most valuable, efficient and cost-effective all-natural concept on the CBD market today with a new product that is easier to consume and ten times more effective and more affordable.” Said Hemp Synergistics Co-Founder, Russ Cersosimo. “There’s truly nothing like it in the world.”
Beintema, ecstatic with the outcome, affirmed: “This is the most effective and efficient product available, significantly better than the oils we have been working with for the last six years.”
Dan Kohler, CEO Hemp Synergistics “We are thrilled to partner with Rinus and we share his passion for patients and their overall wellness. The synergies are boundless and we embrace our continued collaboration on product development for the good of all his patients now, and in the future.”
About Hemp Synergistics: A biotechnology company that specializes in molecular encapsulation of active hemp ingredients, creating new products from scratch, and remediating THC.
SOURCE Hemp Synergistics